Reigniting Colorectal Cancer Screenings During the COVID-19 Pandemic
The COVID-19 pandemic has placed an unprecedented strain on both healthcare organizations and patients that has led to widespread missed colorectal cancer (CRC) screenings. This ECHO series will cover strategies to increase patient activation, optimize clinical workflows, engage care teams, and increase and sustain CRC screening.
At the conclusion of this activity, participatants will be able to:
- Relate the impact of the COVID-19 pandemic on CRC screening rates;
- Recognize gaps in CRC screening completion;
- Identify strategies to promote timely completion of diagnostic colonoscopies;
- Discuss strategies to conduct community outreach and promote CRC screening;
- Review the utility of various outreach strategies for patient activation;
- Recognize the importance of both reminding and recalling patients for CRC screening completion;
- State clinical decision support strategies to address CRC screening gaps;
- Discuss how to use telehealth in promoting cancer screening;
- Identify clinical workflow tweaks to meet the need for CRC screening;
- Relate motivational interviewing techniques to encourage patients to complete CRC screenings;
- List specific strategies to facilitate increased return of fecal immunochemical test (FIT) kits;
- Describe the roles of care teams in promoting and sustaining CRC screening;
- Discuss strategies to promote care team engagement in meeting CRC screening goals.
WANT TO KNOW MORE?
ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact Ella Carr via e-mail at firstname.lastname@example.org.
The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
UNIVERSITY OF CHICAGO COURSE DIRECTOR
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
Please Note: The credit claiming process will close three months after the conference end date. Requests to claim credit after three months will be subject to additional fees.